1. Home
  2. SBLX vs NUWE Comparison

SBLX vs NUWE Comparison

Compare SBLX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBLX
  • NUWE
  • Stock Information
  • Founded
  • SBLX 2017
  • NUWE 1999
  • Country
  • SBLX United States
  • NUWE United States
  • Employees
  • SBLX N/A
  • NUWE N/A
  • Industry
  • SBLX Telecommunications Equipment
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SBLX Consumer Discretionary
  • NUWE Health Care
  • Exchange
  • SBLX Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • SBLX 4.1M
  • NUWE 3.9M
  • IPO Year
  • SBLX N/A
  • NUWE N/A
  • Fundamental
  • Price
  • SBLX $4.70
  • NUWE $4.89
  • Analyst Decision
  • SBLX
  • NUWE
  • Analyst Count
  • SBLX 0
  • NUWE 0
  • Target Price
  • SBLX N/A
  • NUWE N/A
  • AVG Volume (30 Days)
  • SBLX 105.8K
  • NUWE 152.0K
  • Earning Date
  • SBLX 08-14-2025
  • NUWE 08-14-2025
  • Dividend Yield
  • SBLX N/A
  • NUWE N/A
  • EPS Growth
  • SBLX N/A
  • NUWE N/A
  • EPS
  • SBLX N/A
  • NUWE N/A
  • Revenue
  • SBLX $5,426.00
  • NUWE $8,318,000.00
  • Revenue This Year
  • SBLX N/A
  • NUWE $6.53
  • Revenue Next Year
  • SBLX N/A
  • NUWE $51.63
  • P/E Ratio
  • SBLX N/A
  • NUWE N/A
  • Revenue Growth
  • SBLX N/A
  • NUWE N/A
  • 52 Week Low
  • SBLX $4.61
  • NUWE $4.76
  • 52 Week High
  • SBLX $15.28
  • NUWE $175.98
  • Technical
  • Relative Strength Index (RSI)
  • SBLX N/A
  • NUWE 31.85
  • Support Level
  • SBLX N/A
  • NUWE $5.00
  • Resistance Level
  • SBLX N/A
  • NUWE $5.29
  • Average True Range (ATR)
  • SBLX 0.00
  • NUWE 0.35
  • MACD
  • SBLX 0.00
  • NUWE 0.25
  • Stochastic Oscillator
  • SBLX 0.00
  • NUWE 6.63

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: